As of August 20, 2026, the CDC has confirmed 2,777 measles cases in the United States for the year, already surpassing the full 2025 total of 2,289 and marking the highest annual count in over three decades. The outbreak remains driven by sustained community transmission in under-vaccinated populations, with 94% of cases linked to ongoing clusters and recent weekly additions accelerating to 211 new infections. Most cases involve children and adolescents, reflecting MMR coverage gaps below the 95% herd-immunity threshold in affected areas. CDC surveillance updates occur weekly, with the next report expected shortly after August 24; additional confirmed cases through August 31 will depend on continued transmission dynamics and reporting lags from state health departments.
Riepilogo sperimentale generato dall'AI con riferimento ai dati di Polymarket. Questo non è un consiglio di trading e non ha alcun ruolo nella risoluzione di questo mercato. · AggiornatoCasi di morbillo negli Stati Uniti entro il 31 agosto?
Casi di morbillo negli Stati Uniti entro il 31 agosto?
NUOVO
31 ago 2026
2800+
94%
2825+
83%
2850+
78%
$970 Vol.
2800+
$217 Vol.
94%
2825+
$200 Vol.
83%
2850+
$553 Vol.
78%
This market will resolve to "Yes" if there have been the specified amount or more confirmed cases of Measles (Rubeola) in humans in the territory of the United States of America in 2026, according to the CDC case counter by August 31, 2026, 11:59 PM ET. Otherwise, this market will resolve to "No".
The resolution source for this market will be the CDC Measles (Rubeola) counter 'Total Cases' in 2026 (see: https://www.cdc.gov/measles/data-research/index.html) at the resolution time. If the counter becomes unavailable, another credible source will be used.
Note: Only cases reported by the CDC Measles (Rubeola) counter will qualify, regardless of reports from U.S. State agencies or other sources.As of August 20, 2026, the CDC has confirmed 2,777 measles cases in the United States for the year, already surpassing the full 2025 total of 2,289 and marking the highest annual count in over three decades. The outbreak remains driven by sustained community transmission in under-vaccinated populations, with 94% of cases linked to ongoing clusters and recent weekly additions accelerating to 211 new infections. Most cases involve children and adolescents, reflecting MMR coverage gaps below the 95% herd-immunity threshold in affected areas. CDC surveillance updates occur weekly, with the next report expected shortly after August 24; additional confirmed cases through August 31 will depend on continued transmission dynamics and reporting lags from state health departments.
This market will resolve to "Yes" if there have been the specified amount or more confirmed cases of Measles (Rubeola) in humans in the territory of the United States of America in 2026, according to the CDC case counter by August 31, 2026, 11:59 PM ET. Otherwise, this market will resolve to "No".
The resolution source for this market will be the CDC Measles (Rubeola) counter 'Total Cases' in 2026 (see: https://www.cdc.gov/measles/data-research/index.html) at the resolution time. If the counter becomes unavailable, another credible source will be used.
Note: Only cases reported by the CDC Measles (Rubeola) counter will qualify, regardless of reports from U.S. State agencies or other sources.
The resolution source for this market will be the CDC Measles (Rubeola) counter 'Total Cases' in 2026 (see: https://www.cdc.gov/measles/data-research/index.html) at the resolution time. If the counter becomes unavailable, another credible source will be used.
Note: Only cases reported by the CDC Measles (Rubeola) counter will qualify, regardless of reports from U.S. State agencies or other sources.
Mercato aperto: Aug 24, 2026, 10:08 AM ET
Volume
$970Data di fine
31 ago 2026Mercato aperto
Aug 24, 2026, 10:08 AM ETResolver
0x65070BE91...This market will resolve to "Yes" if there have been the specified amount or more confirmed cases of Measles (Rubeola) in humans in the territory of the United States of America in 2026, according to the CDC case counter by August 31, 2026, 11:59 PM ET. Otherwise, this market will resolve to "No".
The resolution source for this market will be the CDC Measles (Rubeola) counter 'Total Cases' in 2026 (see: https://www.cdc.gov/measles/data-research/index.html) at the resolution time. If the counter becomes unavailable, another credible source will be used.
Note: Only cases reported by the CDC Measles (Rubeola) counter will qualify, regardless of reports from U.S. State agencies or other sources.As of August 20, 2026, the CDC has confirmed 2,777 measles cases in the United States for the year, already surpassing the full 2025 total of 2,289 and marking the highest annual count in over three decades. The outbreak remains driven by sustained community transmission in under-vaccinated populations, with 94% of cases linked to ongoing clusters and recent weekly additions accelerating to 211 new infections. Most cases involve children and adolescents, reflecting MMR coverage gaps below the 95% herd-immunity threshold in affected areas. CDC surveillance updates occur weekly, with the next report expected shortly after August 24; additional confirmed cases through August 31 will depend on continued transmission dynamics and reporting lags from state health departments.
This market will resolve to "Yes" if there have been the specified amount or more confirmed cases of Measles (Rubeola) in humans in the territory of the United States of America in 2026, according to the CDC case counter by August 31, 2026, 11:59 PM ET. Otherwise, this market will resolve to "No".
The resolution source for this market will be the CDC Measles (Rubeola) counter 'Total Cases' in 2026 (see: https://www.cdc.gov/measles/data-research/index.html) at the resolution time. If the counter becomes unavailable, another credible source will be used.
Note: Only cases reported by the CDC Measles (Rubeola) counter will qualify, regardless of reports from U.S. State agencies or other sources.
The resolution source for this market will be the CDC Measles (Rubeola) counter 'Total Cases' in 2026 (see: https://www.cdc.gov/measles/data-research/index.html) at the resolution time. If the counter becomes unavailable, another credible source will be used.
Note: Only cases reported by the CDC Measles (Rubeola) counter will qualify, regardless of reports from U.S. State agencies or other sources.
Volume
$970Data di fine
31 ago 2026Mercato aperto
Aug 24, 2026, 10:08 AM ETResolver
0x65070BE91...As of August 20, 2026, the CDC has confirmed 2,777 measles cases in the United States for the year, already surpassing the full 2025 total of 2,289 and marking the highest annual count in over three decades. The outbreak remains driven by sustained community transmission in under-vaccinated populations, with 94% of cases linked to ongoing clusters and recent weekly additions accelerating to 211 new infections. Most cases involve children and adolescents, reflecting MMR coverage gaps below the 95% herd-immunity threshold in affected areas. CDC surveillance updates occur weekly, with the next report expected shortly after August 24; additional confirmed cases through August 31 will depend on continued transmission dynamics and reporting lags from state health departments.
Riepilogo sperimentale generato dall'AI con riferimento ai dati di Polymarket. Questo non è un consiglio di trading e non ha alcun ruolo nella risoluzione di questo mercato. · Aggiornato
Fai attenzione ai link esterni.
Fai attenzione ai link esterni.
Domande frequenti